Should catheter ablation for atrial fibrillation be considered in an 85‑year‑old patient?

Catheter Ablation for AF in an 85-Year-Old Patient

Catheter ablation should be considered in an 85-year-old patient with symptomatic atrial fibrillation, as it is safe and effective in octogenarians, though you must counsel about a modestly higher stroke risk (1.9% vs 0.1%) and slightly higher recurrence rates compared to younger patients.

Guideline Framework

The 2024 ESC guidelines 1 recommend catheter ablation as a first-line rhythm control strategy (Class I, Level A) for symptomatic paroxysmal AF and should be considered (Class IIa, Level B) for persistent AF. Critically, these guidelines do not exclude patients based on age alone—the decision hinges on symptoms, patient preference, and overall fitness rather than chronological age.

Evidence in the Very Elderly

Efficacy Data

The most recent and highest-quality evidence comes from the 2026 REHEALTH AF Study 2, a prospective multicenter registry of 703 patients ≥80 years old. This study demonstrates:

• No difference in primary composite outcomes (stroke, TIA, cardiovascular events, bleeding, death) in unadjusted analysis
• Significant benefit emerged after multivariable adjustment (adjusted HR: 0.44, p=0.029)
• Meaningful improvements at 1 year: symptoms, quality of life, NT-proBNP levels, left atrial diameter, and preservation of cognitive function (Mini-Mental State Examination) and frailty scores

A 2024 large registry analysis 3 of 7,020 patients (16% very elderly >75 years) showed:

• Major complications <1.5% across all age groups
• AF recurrence at 3 years: 48% in very elderly with persistent AF vs 36% in younger patients
• Quality of life improved significantly regardless of age

Safety Profile

The safety data requires nuanced interpretation:

• Periprocedural stroke risk is higher: 1.9% vs 0.1% in younger patients 4
• Pericardial effusion rates increase with age 3, though remain manageable
• Overall major complication rates remain low (<1.5%) and acceptable 3, 5
• A 2023 UC San Diego registry 5 found no statistical difference in complications between octogenarians and younger patients

Success Rates

Multiple studies converge on similar efficacy:

• 69-72% freedom from AF after single procedure 5, 6
• 87% success after repeat procedures 6
• Higher rate of non-pulmonary vein triggers (84% vs 69%) requiring more extensive ablation 6

Clinical Decision Algorithm

Proceed with ablation if:

1. Symptomatic AF causing reduced quality of life
2. Reasonable functional status (not severely frail)
3. Patient preference for rhythm control after shared decision-making
4. Failed or intolerant to antiarrhythmic drugs (though first-line ablation is also reasonable per guidelines 1)

Exercise caution but don't exclude if:

• Paroxysmal AF (similar success to younger patients 3)
• Persistent AF (higher recurrence but still 52% success at 3 years 3)
• Multiple comorbidities (adjust expectations but benefits persist 2)

Key counseling points:

• Stroke risk: 1 in 50 chance of periprocedural stroke vs 1 in 1000 in younger patients 4
• Recurrence: Approximately 30% higher risk than younger patients 7
• Quality of life: Expect significant improvement regardless of arrhythmia-free status 2, 3
• Cognitive preservation: Ablation may help maintain cognitive function 2

Critical Pitfalls to Avoid

1. Don't assume age alone is a contraindication—the 2024 ESC guidelines 1 emphasize individualized assessment, not age cutoffs

2. Don't discontinue anticoagulation post-ablation based on procedural success—continue OAC based on CHA₂DS₂-VASc score per 2020 Canadian guidelines 8, as ablation doesn't eliminate stroke risk

3. Don't underestimate non-pulmonary vein triggers—octogenarians have 84% incidence 6, requiring more comprehensive ablation including coronary sinus, left atrial appendage, and superior vena cava

4. Don't overlook the quality of life benefit—even with higher recurrence rates, functional improvements are substantial and clinically meaningful 2, 3

Anticoagulation Management

Per Canadian guidelines 8:

• Continue uninterrupted OAC during the procedure
• Mandatory 2 months post-ablation regardless of success
• Long-term OAC decision based on stroke risk score (CHA₂DS₂-VASc), not ablation outcome

This 85-year-old patient almost certainly has a CHA₂DS₂-VASc ≥2 (age alone gives 2 points), so lifelong anticoagulation should continue regardless of ablation success.